文献速递角膜与眼表疾病

DMEK术后再次注气与移植失败的前瞻性荷兰登记研究

Rebubbling and graft failure in Descemet membrane endothelial keratoplasty: a prospective Dutch registry study.
PubMed 文献 · Br J Ophthalmol · 2021-02-17

该前瞻性登记研究纳入荷兰器官移植登记处全部连续DMEK手术752眼,分析再次注气的危险因素及早期移植失败。19%眼接受再次注气,再次注气眼移植失败率显著更高(30% vs 9%),且术后一年内皮细胞密度显著更低。独立危险因素包括受者年龄和手术并发症(再次注气),以及2016年前移植和手术并发症(早期移植失败)。

要点

  • DMEK术后19%眼需再次注气,其中70%成功。
  • 再次注气眼移植失败率30% vs 9%(OR 4.28),内皮细胞密度显著更低。
  • 手术并发症和受者年龄是再次注气的独立危险因素。

核心结论

  • 再次注气的独立危险因素为受者年龄和手术并发症,早期移植失败的独立危险因素为2016年前移植和手术并发症。
  • 再次注气与术后第一年显著更高的内皮细胞丢失相关。

研究设计与样本

  • 前瞻性登记研究,纳入荷兰器官移植登记处全部连续DMEK手术752眼。
  • 采用逻辑回归进行单变量和多变量分析,线性混合模型分析再次注气对内皮细胞密度的影响。

主要发现

  • 752眼中144眼(19%)接受再次注气,其中101眼(70%)成功。
  • 再次注气眼移植失败率为30%,未再次注气眼为9%(OR 4.28,95%CI 2.72-6.73,p<0.001)。
  • 再次注气独立危险因素:手术并发症(OR 2.28,95%CI 1.20-4.33,p=0.012)、受者年龄每增加1岁(OR 1.04,95%CI 1.01-1.07,p=0.003)。
  • 3个月内移植失败危险因素:2016年前移植(OR 3.32,95%CI 1.87-5.90,p<0.001)、手术并发症(OR 2.93,95%CI 1.42-6.04,p=0.004)。
  • 再次注气眼在3、6、12个月的内皮细胞密度显著低于未再次注气眼(均p<0.001)。

临床怎么用

  • 对高龄或术中出现并发症的DMEK患者应警惕再次注气风险。
  • 再次注气后需密切监测内皮细胞密度和移植失败迹象。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To identify risk factors for rebubbling, and early graft failure after Descemet membrane endothelial keratoplasty (DMEK). METHODS: In this prospective registry study, all consecutive DMEK procedures registered in the Netherlands Organ Transplant Registry were assessed (n=752). Univariable and multivariable analysis was performed using logistic regression. The effect of rebubbling on endothelial cell density was analysed using a linear mixed model. RESULTS: 144 of 752 (19%) eyes underwent rebubbling. Rebubbling was successful in 101 eyes (70%). In eyes that underwent rebubbling, the graft failure rate was significantly higher than eyes that did not undergo rebubbling (30% vs 9%, respectively; OR: 4.28, 95% CI 2.72 to 6.73, p<0.001). In multivariable analysis, independent risk factors for rebubbling were surgical complication (OR: 2.28, 95% CI 1.20 to 4.33, p=0.012) and older recipient age (OR: 1.04 (per increase of 1 year), 95% CI 1.01 to 1.07, p=0.003). Risk factors for developing graft failure within 3 months were transplant before 2016 (OR: 3.32, 95% CI 1.87 to 5.90, p<0.001), and surgical complication (OR: 2.93, 95% CI 1.42 to 6.04, p=0.004). Throughout the study period, rebubbling and early graft failure were inversely related. Eyes that underwent rebubbling showed significantly lower endothelial cell densities at 3, 6 and 12 months compared with eyes that did not undergo rebubbling (all p<0.001). CONCLUSIONS: This Dutch registry study identified independent risk factors for DMEK graft detachment leading to rebubbling, namely recipient age and surgical complication, and early graft failure, namely transplantation before 2016 and surgical complication. Rebubbling was associated with significantly higher endothelial cell loss in the first year after surgery.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Dunker S, Winkens B, van den Biggelaar F, et al. Rebubbling and graft failure in Descemet membrane endothelial keratoplasty: a prospective Dutch registry study. Br J Ophthalmol. 2021. PMID: 33597192. doi:10.1136/bjophthalmol-2020-317041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。